No Data
Express News | Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success Through Patient Affordability
Express News | Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (Hpv), Advancing Tvgn 920
Express News | Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI Into Preclinical Processes, Accelerating Drug Development and Reducing Costs
Express News | Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
Express News | Tevogen Bio to Provide Timelines Associated With Recently Announced Revenue Forecast and Updates on Operational Readiness This Week
Moomoo Buddy : Dear client, the strike price is 11.50USD, for more details you can send the email to us corporateactions@sg.moomoo.com,thank you.